| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 22 Aug 2026 | 22 Aug 2026 |
| This is to inform that the Board of Directors of the Company at their Meeting held on 22nd August 2026 approved: i) the appointment of Independent Director i.e. Ms. Aritika Garg (DIN: 11895058) was appointed as an Additional Director on the Board of the Company (Non-Executive, Independent Director) subject to the approval of members at the ensuing AGM of the Company. The disclosure required to be given pursuant to SEBI Circular is enclosed as Annexure A. Please note that the meeting of the Board of Directors commenced at 03:00 P.M. and concluded at 03:30 P.M. | ||
| Board Meeting | 13 Aug 2026 | 5 Aug 2026 |
| Quarterly Results M K Proteins Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026 approvaed by the Board of Directors of the Company at the Board Meeting held today i.e. on 13th August 2026. As Per NSE Announcement Dated On : 13.06.2026) | ||
| Board Meeting | 29 May 2026 | 18 May 2026 |
| M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Financial Results for FY 2025-26 and other business matters on Friday, 29.05.2026. M K Proteins Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. (As Per NSE Announcement Dated On : 29.05.2026) To consider and approve the financial results for the year ended March 31, 2026 and other business matters (As Per NSE Announcement Dated On : 18.05.2026) | ||
| Board Meeting | 13 Feb 2026 | 5 Feb 2026 |
| Quarterly Results M K Proteins Limited has submitted to the Exchange, the Un-Audited Financial Results of the Company for the quarter and nine months ended 31st December, 2025. Un-Audited Financial Results along with the Limited Review Report (LRR) of the Company for the quarter and nine months ended 31st December, 2025 are enclosed. (As Per NSE Announcement Dated On : 13.02.2026) | ||
| Board Meeting | 14 Nov 2025 | 4 Nov 2025 |
| M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve 1. The Un-audited Financial Results of the Company for the quarter and half year ended 30th September 2025; 2. Any other items with the permission of the chairman. M K Proteins Limited has submitted to the Exchange, Un-Audited Financial Results for the quarter and half year ended September 30, 2025 along with the Limited Review Report thereon by the Statutory Auditors of the Company. (As Per NSE Announcement Dated On : 14.11.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
